Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Yoshimura (Kyoto, Japan), T. Tsuji (Kyoto, Japan), C. Takumi (Kyoto, Japan), R. Hamashima (Kyoto, Japan), S. Shiotsu (Kyoto, Japan), T. Yuba (Kyoto, Japan), N. Hiraoka (Kyoto, Japan). Prognosis of uncommon metastasis in non-small-cell lung cancer patients with mutated EGFR. 2801

Member's Comments

No comment yet.

Related content which might interest you: How to treat brain metastasis in patients with non-small cell lung carcinoma (NSCLC) and EGFR mutations Source: International Congress 2015 – How to treat brain metastases Year: 2015 Detecting extrathoracic metastases in patients with non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 41s Year: 2006 Management of patients with non-small-cell lung cancer Source: ERS Live 2007 Year: 2007 Management of brain metastases in patients with non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Management of EGFR mutated nonsmall cell lung carcinoma patients Source: Eur Respir J 2015; 45: 1132-1141 Year: 2015 A rare choroidal metastasis in ALK+ non-small cell lung cancer (NSCLC) that responds to Crizotinib Source: International Congress 2019 – CCC Thoracic oncology Year: 2019 Breast metastasis in association with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 538s Year: 2005 MDM-2 gene amplification is associated with poor prognosis in operable non-small cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002 Progression after osimertinib in EGFR T790M-mutated non-small cell cancer patients Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020 Do cavitating non-small cell lung cancer patients have a more aggressive disease? Source: Eur Respir J 2006; 28: Suppl. 50, 84s Year: 2006 Early recurrence in complete resected non-small cell lung cancer patients Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons Year: 2017 Pulmonary re-biopsy in non–small-cell lung cancer (NSCLC) locally advanced or metastatic  with EGFR-T790M resistance. Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound Year: 2018 A rare involvement in a male patient with non-small cell lung carcinoma: breast metastasis Source: Eur Respir J 2005; 26: Suppl. 49, 538s Year: 2005 Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation Source: Eur Respir J 2011; 37: 624-631 Year: 2011 Prognostic factors for unresectable non-small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 270s Year: 2002 Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006 Fascin-1 overexpression predicts a poor prognosis in non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Possibility of the specific efficacy of gefitinib for miliary lung metastasis in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 303s Year: 2004 Prognostic  value of  EGFR  genotype  in  EGFR-mutant  non-small  cell lung  cancer Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018